Portfolio company
OverT Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops engineered cell therapies and genetic screening platforms to treat patients with solid tumour cancers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
OverT
This biotechnology company develops engineered cell therapies for the treatment of solid tumours in cancer patients.
Waypoint Bio
This company develops cell therapies for solid tumours using a spatial biology and machine learning platform to assist patients with difficult-to-treat cancers.
Vivere Oncotherapies
This company develops engineered cancer immunotherapies to help the immune systems of patients with solid tumours detect and destroy malignant cells.
Siren Bio
This company develops immuno-gene therapies combining viral gene delivery and cytokine immunotherapy to treat solid tumours for cancer patients.
Avenge Bio
This biotechnology firm develops cell-based immunotherapies for patients with solid tumours, specifically targeting metastatic peritoneal cancers like ovarian cancer.
OPS-γδ
This company develops an engineered gamma delta T cell therapy platform to treat patients with solid tumours.
Outpace Bio
This biotechnology company develops custom protein-designed cell therapies to treat solid tumours and autoimmune diseases for patients and pharmaceutical partners.
Captain T Cell
The company develops cell therapies for cancer patients to treat solid tumours.
